Article
In vivo human T cell engineering with enveloped delivery vehicles
11 Jan 2024
Abstract excerpt
Viruses and virally derived particles have the intrinsic capacity to deliver molecules to cells, but the difficulty of readily altering cell-type selectivity has hindered their use for therapeutic delivery. Here, we show that cell surface marker recognition by antibody fragments displayed on membrane-derived particles encapsulating CRISPR-Cas9 protein and guide RNA can deliver genome editing tools to specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
